In addition to gastrointestinal side effects, participants also reported mild-to-moderate neuropsychiatric issues, primarily anxiety, irritability and sleep disturbances
10.2147/DDDT.S356307 [DOI] [PMC free article] [PubMed] [Google Scholar] 348.Qin, D
The CD38/NAD/SIRTUIN1/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections
Mice were randomized into seven groups: a saline control group (CON), a saline control treated with GHRP-6 (CON + GHRP-6), a doxorubicin-only group (DOX), a doxorubicin group treated with GHRP-6 (DOX + GHRP-6), a doxorubicin group treated with GHRP-6 and the GHSR antagonist YIL781 (DOX + GHRP-6 + YIL781), a doxorubicin group treated with GHRP-6 and the CCR5 antagonist TAK-779 (DOX + GHRP-6 + TAK-779), and finally a doxorubicin group treated with GHRP-6 alongside the CXCR4 antagonist AMD3100 (DOX + GHRP-6 + AMD3100)
Most Common Side Effects The most frequently reported side effects of GLP-1 medications are gastrointestinal